These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

218 related items for PubMed ID: 308967

  • 1. In vitro studies of the rabbit immune system. VI. Rabbit anti-mouse cytotoxic T effector cells are inhibited by anti-rabbit T cell serum in the absence of complement.
    Redelman D, Trefts PE.
    J Immunol; 1978 Oct; 121(4):1532-9. PubMed ID: 308967
    [Abstract] [Full Text] [Related]

  • 2. Studies on the cytolytic attack mechanism of the cytotoxic T lymphocyte (CTL): preparation of antisera against cellfree cytosolic extracts of a CTL clone capable of blocking the lethal hit stage of CTL cytolysis and analysis of the cytolytic structure.
    Hiserodt JC.
    J Immunol; 1985 Jul; 135(1):53-62. PubMed ID: 3158707
    [Abstract] [Full Text] [Related]

  • 3. Effect of rabbit anti-asialo GM1 treatment in vivo or with anti-asialo GM1 plus complement in vitro on cytotoxic T cell activities.
    Stitz L, Baenziger J, Pircher H, Hengartner H, Zinkernagel RM.
    J Immunol; 1986 Jun 15; 136(12):4674-80. PubMed ID: 3486908
    [Abstract] [Full Text] [Related]

  • 4. Expression of Qat-4 and Qat-5 alloantigens on cytotoxic precursor and effector cells: different surface phenotypes of alloreactive and H-2 restricted cytotoxic T cells.
    Zahn G, Hämmerling GJ, Eichmann K, Simon MM.
    Eur J Immunol; 1982 Jan 15; 12(1):43-50. PubMed ID: 6977451
    [Abstract] [Full Text] [Related]

  • 5. Inhibition of human antibody-dependent cellular cytotoxicity, cell-mediated cytotoxicity, and natural killing by a xenogeneic antiserum prepared against "activated" alloimmune human lymphocytes.
    Neville ME, Hiserodt JC.
    J Immunol; 1982 Mar 15; 128(3):1246-51. PubMed ID: 6976989
    [Abstract] [Full Text] [Related]

  • 6. IgM antibody-dependent cell-mediated cytotoxicity in the Moloney sarcoma virus system: the involvement of T and B lymphocytes as effector cells.
    Lamon EW, Whitten HD, Skurzak HM, Andersson B, Lidin B.
    J Immunol; 1975 Nov 15; 115(5):1288-94. PubMed ID: 1080777
    [Abstract] [Full Text] [Related]

  • 7. Requirements for T cells in alloantigen-induced generation of non-T cell-mediated cytotoxicity against syngeneic mouse sarcoma cells.
    Paciucci PA, Macphail S, Bach FH, Zarling JM.
    J Immunol; 1980 Jul 15; 125(1):36-9. PubMed ID: 6155401
    [Abstract] [Full Text] [Related]

  • 8. Helper cells in murine thymus for the generation of primary cytolytic T lymphocyte (CTL) responses in vitro.
    Wu S, Bach FH.
    J Immunol; 1981 Feb 15; 126(2):775-80. PubMed ID: 6969763
    [Abstract] [Full Text] [Related]

  • 9. Cell surface receptors involved in the attachment of murine cytotoxic T lymphocytes to target cells - a study with xenoantisera to T-cell antigens.
    Rabinowitz R, Levy J, Schlesinger M.
    Thymus; 1983 Apr 15; 5(3-4):127-39. PubMed ID: 6603681
    [Abstract] [Full Text] [Related]

  • 10. Induction and characterization of minor histocompatibility antigens. Specific primary cytotoxic T lymphocyte responses in vitro.
    Ando K, Nakashima I, Nagase F, Isobe K, Kawashima K, Hasegawa Y, Yoshida T, Iwamoto T, Hasegawa T, Muro Y.
    J Immunol; 1988 Feb 01; 140(3):723-9. PubMed ID: 2448374
    [Abstract] [Full Text] [Related]

  • 11. Specific and nonspecific antitumor immunity. I. Description of an in vitro assay based on inhibition of DNA synthesis in tumor cells.
    Williams RM, Germain RN, Benacerraf B.
    J Natl Cancer Inst; 1975 Mar 01; 54(3):697-708. PubMed ID: 1091740
    [Abstract] [Full Text] [Related]

  • 12. Cytotoxic effects of antigen- and mitogen-induced T cells on various targets.
    Bevan MJ, Cohn M.
    J Immunol; 1975 Feb 01; 114(2 Pt 1):559-65. PubMed ID: 123541
    [Abstract] [Full Text] [Related]

  • 13. Active suppression of host-vs-graft reaction in pregnant mice. VI. Soluble suppressor activity obtained from decidua of allopregnant mice blocks the response to IL 2.
    Clark DA, Chaput A, Walker C, Rosenthal KL.
    J Immunol; 1985 Mar 01; 134(3):1659-64. PubMed ID: 3871455
    [Abstract] [Full Text] [Related]

  • 14. Capacity of different cell types to stimulate cytotoxic T lymphocyte precursor cells in the presence of interleukin 2.
    Dröge W, Moyers C, Wehrmaker A, Schmidt H, Panknin S, Männel D, Falk W.
    J Immunol; 1984 Jun 01; 132(6):2749-59. PubMed ID: 6233360
    [Abstract] [Full Text] [Related]

  • 15. In vitro stimulation and inhibition of tumor cell growth mediated by different lymphoid cell populations.
    Norbury KC.
    Cancer Res; 1977 May 01; 37(5):1408-15. PubMed ID: 66982
    [Abstract] [Full Text] [Related]

  • 16. Induction and properties of cytotoxic T cells specific for hapten-coupled tumor cells.
    Dennert G, Hatlen LE.
    J Immunol; 1975 Jun 01; 114(6):1705-12. PubMed ID: 805174
    [Abstract] [Full Text] [Related]

  • 17. Xenoantisera against a murine T cell tumor product cross-react with immunoglobulin Fab determinants.
    Mackel AM, Craddock GR, Warr GW, DeLuca D, Marchalonis JJ.
    J Immunol; 1983 Sep 01; 131(3):1582-90. PubMed ID: 6350458
    [Abstract] [Full Text] [Related]

  • 18. Activation of nonspecific killer cells by interleukin 2-containing supernatants.
    Teh HS, Yu M.
    J Immunol; 1983 Oct 01; 131(4):1827-33. PubMed ID: 6194216
    [Abstract] [Full Text] [Related]

  • 19. Detection of a unique antigen on radiation leukemia virus-induced leukemia B6RV2.
    Nakayama E, Uenaka A, Stockert E, Obata Y.
    Cancer Res; 1984 Nov 01; 44(11):5138-44. PubMed ID: 6091870
    [Abstract] [Full Text] [Related]

  • 20. Functional activity in vivo of effector T cell populations. II. Anti-tumor activity exhibited by syngeneic anti-MoMULV-specific cytolytic T cell clones.
    Engers HD, Lahaye T, Sorenson GD, Glasebrook AL, Horvath C, Brunner KT.
    J Immunol; 1984 Sep 01; 133(3):1664-70. PubMed ID: 6205090
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.